Asia Pacific Next-Generation Sequencing Market

Asia Pacific Next-Generation Sequencing Market size was valued at USD 3.4 billion in 2025 and is forecast to grow from USD 3.8 billion in 2026 to reach USD 7.3 billion by 2031, at a CAGR of 16.5%.

Description

The Asia Pacific Next-Generation Sequencing Market size was valued at USD 3.4 billion in 2025 and is forecast to grow from USD 3.8 billion in 2026 to reach USD 7.3 billion by 2031, at a CAGR of 16.5%. Next-generation sequencing encompasses high-throughput genomic technologies that enable rapid, parallel sequencing of DNA and RNA at significantly reduced cost compared to traditional Sanger sequencing, supporting applications across oncology, reproductive health, infectious disease surveillance, and agrigenomics. The market sits at the intersection of precision medicine, clinical diagnostics, and genomics research, making it one of the most closely watched enabling technologies across the regional life-sciences and healthcare value chain.

Demand for next-generation sequencing platforms remains anchored by expanding cancer genomic profiling, growing national genomics initiatives, and rising government investment in precision-medicine infrastructure across China, Japan, India, and South Korea. Beyond clinical diagnostics, NGS continues to enable applications in reproductive health screening, infectious disease surveillance, agricultural genomics, and pharmaceutical drug-discovery research. Rising healthcare expenditure, declining sequencing costs, and continued government support for domestic genomics and biotechnology innovation are sustaining consumption even as the region transitions toward more decentralized, clinically integrated sequencing workflows.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • Asia Pacific Next-Generation Sequencing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product (Consumables & Reagents, Instruments, Services, Others)

      2. By Application (Oncology, Reproductive Health, Infectious Disease Diagnostics, Agrigenomics, Others)

      3. By End User (Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • China Next-Generation Sequencing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Japan Next-Generation Sequencing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • India Next-Generation Sequencing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • South Korea Next-Generation Sequencing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Australia Next-Generation Sequencing Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • Asia Pacific Next-Generation Sequencing Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Illumina, Inc.

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. Thermo Fisher Scientific Inc.

    3. BGI Genomics Co., Ltd.

    4. Pacific Biosciences of California, Inc.

    5. Agilent Technologies, Inc.

    6. Oxford Nanopore Technologies plc

    7. F. Hoffmann-La Roche Ltd

    8. QIAGEN N.V.

    9. MGI Tech Co., Ltd.

    10. Singular Genomics Systems, Inc.

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology